
Biomarker is basically a molecule that is found in the body fluid or tissues and blood, which indicates the normal and abnormal functions of the body. A biomarker is used in the entire drug discovery as well as the development process for understanding fundamental biological processes and their relationship. By utilizing different technologies, new biomarkers are discovered to unlock new decrease progression. As biomarkers have the capacity to diagnose various diseases at an initial stage, it is widely used to detect cancer and treat the disease.
These days biomarkers technologies market is making expansion owing to advancements in the field of discovery and technologies. In 2021, the global biomarker technologies market was valued at USD 32,600.71 million it is anticipated to grow at a CAGR of 11.3% during the forecast period, according to a new market study by Quince Market Insights. Various companies are witnessing huge growth in the biomarker technologies market. Here we have listed the top 10 companies operating in the global biomarker technologies market.
Thermo Fisher Scientific, Inc. (U.S.)
Based in Waltham, Massachusetts, United States, Thermo Fisher Scientific is basically an American provisionary of scientific instrumentations, consumables, reagents, and software services. The company has made a significant presence in the global biomarker technologies market. In July 2020, the company consented to partner symptomatic arrangements with Chugai Pharmaceutical to expand the use of the Oncomine Dx Target Test and facilitate nearby biomarker testing of non-little cell cellular breakdown in the lungs patients qualified for treatment in Japan. The company has also collaborated with Newomics, which is the main provider of microfluidics for fluid chromatography-mass spectrometry applications.